Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Pathways for HIV Prevention Behaviors Following a Home-Based Couples Intervention for Pregnant Women and Male Partners in Kenya.

Hatcher AM, Darbes L, Kwena Z, Musoke PL, Rogers AJ, Owino G, Helova A, Anderson JL, Oyaro P, Bukusi EA, Turan JM.

AIDS Behav. 2020 Jan 1. doi: 10.1007/s10461-019-02774-4. [Epub ahead of print]

PMID:
31894444
2.

Erratum to: Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012.

Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH.

J Infect Dis. 2020 Feb 18;221(5):855. doi: 10.1093/infdis/jiz524. No abstract available.

PMID:
31776582
3.

Complexities of HIV Disclosure in Patients Newly Entering HIV Care: A Qualitative Analysis.

Chapman Lambert C, Tarver WL, Musoke PL, Stringer KL, Whitfield S, Turan B, Modi R, Mugavero MJ, Fredericksen RJ, Weiser S, Johnson MO, Turan JM.

J Assoc Nurses AIDS Care. 2020 Mar-Apr;31(2):208-218. doi: 10.1097/JNC.0000000000000127.

4.

A hospital-based birth defects surveillance system in Kampala, Uganda.

Mumpe-Mwanja D, Barlow-Mosha L, Williamson D, Valencia D, Serunjogi R, Kakande A, Namale-Matovu J, Nankunda J, Birabwa-Male D, Okwero MA, Nsungwa-Sabiiti J, Musoke P.

BMC Pregnancy Childbirth. 2019 Oct 22;19(1):372. doi: 10.1186/s12884-019-2542-x.

5.

Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda.

Nakatudde I, Rujumba J, Namiiro F, Sam A, Mugalu J, Musoke P.

PLoS One. 2019 Sep 6;14(9):e0221902. doi: 10.1371/journal.pone.0221902. eCollection 2019.

6.

Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.

Li G, Bielicki JA, Ahmed ASMNU, Islam MS, Berezin EN, Gallacci CB, Guinsburg R, da Silva Figueiredo CE, Santarone Vieira R, Silva AR, Teixeira C, Turner P, Nhan L, Orrego J, Pérez PM, Qi L, Papaevangelou V, Triantafyllidou P, Iosifidis E, Roilides E, Sarafidis K, Jinka DR, Nayakanti RR, Kumar P, Gautam V, Prakash V, Seeralar A, Murki S, Kandraju H, Singh S, Kumar A, Lewis L, Pukayastha J, Nangia S, K N Y, Chaurasia S, Chellani H, Obaro S, Dramowski A, Bekker A, Whitelaw A, Thomas R, Velaphi SC, Ballot DE, Nana T, Reubenson G, Fredericks J, Anugulruengkitt S, Sirisub A, Wong P, Lochindarat S, Boonkasidecha S, Preedisripipat K, Cressey TR, Paopongsawan P, Lumbiganon P, Pongpanut D, Sukrakanchana PO, Musoke P, Olson L, Larsson M, Heath PT, Sharland M.

Arch Dis Child. 2020 Jan;105(1):26-31. doi: 10.1136/archdischild-2019-316816. Epub 2019 Aug 24. Erratum in: Arch Dis Child. 2020 Mar 27;:.

7.

Serum Vitamin D is Differentially Associated with Socioemotional Adjustment in Early School-Aged Ugandan Children According to Perinatal HIV Status and In Utero/Peripartum Antiretroviral Exposure History.

Yakah W, Fenton JI, Sikorskii A, Zalwango SK, Tuke R, Musoke P, Boivin MJ, Giordani B, Ezeamama AE.

Nutrients. 2019 Jul 12;11(7). pii: E1570. doi: 10.3390/nu11071570.

8.

Serum n-6 Fatty Acids are Positively Associated with Growth in 6-to-10-Year Old Ugandan Children Regardless of HIV Status-A Cross-Sectional Study.

Jain R, Ezeamama AE, Sikorskii A, Yakah W, Zalwango S, Musoke P, Boivin MJ, Fenton JI.

Nutrients. 2019 Jun 4;11(6). pii: E1268. doi: 10.3390/nu11061268.

9.

Development of a Novel Scale to Measure Male Partner Involvement in the Prevention of Mother-to-Child Transmission of HIV in Kenya.

Hampanda K, Abuogi L, Musoke P, Onono M, Helova A, Bukusi E, Turan J.

AIDS Behav. 2020 Jan;24(1):291-303. doi: 10.1007/s10461-019-02546-0.

10.

Caregiver socioemotional health as a determinant of child well-being in school-aged and adolescent Ugandan children with and without perinatal HIV exposure.

Webster KD, de Bruyn MM, Zalwango SK, Sikorskii A, Barkin JL, Familiar-Lopez I, Musoke P, Giordani B, Boivin MJ, Ezeamama AE.

Trop Med Int Health. 2019 May;24(5):608-619. doi: 10.1111/tmi.13221. Epub 2019 Mar 13.

PMID:
30809898
11.

The role of women's empowerment and male engagement in pregnancy healthcare seeking behaviors in western Kenya.

Bello FO, Musoke P, Kwena Z, Owino GO, Bukusi EA, Darbes L, Turan JM.

Women Health. 2019 Sep;59(8):892-906. doi: 10.1080/03630242.2019.1567644. Epub 2019 Feb 7.

PMID:
30727846
12.

Factors Influencing the Risk of Becoming Sexually Active Among HIV Infected Adolescents in Kampala and Kisumu, East Africa.

Bakeera-Kitaka S, Smekens T, Jespers V, Wobudeya E, Loos J, Colebunders R, Adipo D, Kekitiinwa A, Musoke P, Buve A, Nöstlinger C.

AIDS Behav. 2019 Jun;23(6):1375-1386. doi: 10.1007/s10461-018-2323-y.

PMID:
30406334
13.

Courage and confidence to stop lying: caregiver perspectives on a video to support paediatric HIV disclosure in Kampala, Uganda.

Klingberg S, King R, Seeley J, Lubwama R, Namuganga M, Nabiryo B, Etima M, Musoke P, Butler LM.

Afr J AIDS Res. 2018 Sep;17(3):273-279. doi: 10.2989/16085906.2018.1521850.

PMID:
30355059
14.

Comparative effects of three methods of promoting breastfeeding among human immunodeficiency virus-infected women in Uganda: a parallel randomized clinical trial.

Namale-Matovu J, Owora AH, Onyango-Makumbi C, Mubiru M, Namuli PE, Motevalli-Oliner M, Musoke P, Nolan M, Fowler MG.

Int Health. 2018 Nov 1;10(6):430-441. doi: 10.1093/inthealth/ihy041.

15.

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.

Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S, Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A, Crook AM, Cotton M, Gibb DM; SHINE trial team.

Trials. 2018 Apr 19;19(1):237. doi: 10.1186/s13063-018-2608-5.

16.

Development and Piloting of a Home-Based Couples Intervention During Pregnancy and Postpartum in Southwestern Kenya.

Turan JM, Darbes LA, Musoke PL, Kwena Z, Rogers AJ, Hatcher AM, Anderson JL, Owino G, Helova A, Weke E, Oyaro P, Bukusi EA.

AIDS Patient Care STDS. 2018 Mar;32(3):92-103. doi: 10.1089/apc.2017.0285.

17.

Men's hopes, fears and challenges in engagement in perinatal health and the prevention of mother-to-child transmission of HIV in rural Kenya.

Musoke P, Hatcher A, Rogers AJ, Achiro L, Bukusi E, Darbes L, Kwena Z, Oyaro P, Weke E, Turan JM.

Cult Health Sex. 2018 Nov;20(11):1259-1272. doi: 10.1080/13691058.2018.1426785. Epub 2018 Feb 21.

18.

Recent progress in immune-based interventions to prevent HIV-1 transmission to children.

Voronin Y, Jani I, Graham BS, Cunningham CK, Mofenson LM, Musoke PM, Permar SR, Scarlatti G.

J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25038.

19.

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.

Szubert AJ, Prendergast AJ, Spyer MJ, Musiime V, Musoke P, Bwakura-Dangarembizi M, Nahirya-Ntege P, Thomason MJ, Ndashimye E, Nkanya I, Senfuma O, Mudenge B, Klein N, Gibb DM, Walker AS; ARROW Trial Team.

PLoS Med. 2017 Nov 14;14(11):e1002432. doi: 10.1371/journal.pmed.1002432. eCollection 2017 Nov.

20.

A Text Messaging Intervention to Support Option B+ in Kenya: A Qualitative Study.

Musoke P, Gakumo CA, Abuogi LL, Akama E, Bukusi E, Helova A, Nalwa WZ, Onono M, Spangler SA, Wanga I, Turan JM.

J Assoc Nurses AIDS Care. 2018 Mar - Apr;29(2):287-299. doi: 10.1016/j.jana.2017.09.009. Epub 2017 Oct 3.

21.

Partnerships for Global Child Health.

Steenhoff AP, Crouse HL, Lukolyo H, Larson CP, Howard C, Mazhani L, Pak-Gorstein S, Niescierenko ML, Musoke P, Marshall R, Soto MA, Butteris SM, Batra M; GH Task Force of the American Board of Pediatrics.

Pediatrics. 2017 Oct;140(4). pii: e20163823. doi: 10.1542/peds.2016-3823. Epub 2017 Sep 20. Review.

22.

From 'half-dead' to being 'free': resistance to HIV stigma, self-disclosure and support for PMTCT/HIV care among couples living with HIV in Kenya.

Spangler SA, Abuogi LL, Akama E, Bukusi EA, Helova A, Musoke P, Nalwa WZ, Odeny TA, Onono M, Wanga I, Turan JM.

Cult Health Sex. 2018 May;20(5):489-503. doi: 10.1080/13691058.2017.1359338. Epub 2017 Aug 16.

23.

Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.

Barlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G, Penazzato M.

J Int AIDS Soc. 2017 Jun 27;20(1):21552. doi: 10.7448/IAS.20.1.21552. Review.

24.

Quality of life among perinatally HIV-affected and HIV-unaffected school-aged and adolescent Ugandan children: a multi-dimensional assessment of wellbeing in the post-HAART era.

Nkwata AK, Zalwango SK, Kizza FN, Sekandi JN, Mutanga J, Zhang M, Musoke PM, Ezeamama AE.

Qual Life Res. 2017 Sep;26(9):2397-2408. doi: 10.1007/s11136-017-1597-2. Epub 2017 May 22.

PMID:
28534093
25.

Health facility challenges to the provision of Option B+ in western Kenya: a qualitative study.

Helova A, Akama E, Bukusi EA, Musoke P, Nalwa WZ, Odeny TA, Onono M, Spangler SA, Turan JM, Wanga I, Abuogi LL.

Health Policy Plan. 2017 Mar 1;32(2):283-291. doi: 10.1093/heapol/czw122.

26.

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.

Hobbs CV, Gabriel EE, Kamthunzi P, Tegha G, Tauzie J, Petzold E, Barlow-Mosha L, Chi BH, Li Y, Ilmet T, Kirmse B, Neal J, Parikh S, Deygoo N, Jean Philippe P, Mofenson L, Prescott W, Chen J, Musoke P, Palumbo P, Duffy PE, Borkowsky W; P1068s Study Team.

PLoS One. 2016 Dec 9;11(12):e0165140. doi: 10.1371/journal.pone.0165140. eCollection 2016.

27.

Couple interdependence impacts HIV-related health behaviours among pregnant couples in southwestern Kenya: a qualitative analysis.

Rogers AJ, Achiro L, Bukusi EA, Hatcher AM, Kwena Z, Musoke PL, Turan JM, Weke E, Darbes LA.

J Int AIDS Soc. 2016 Nov 24;19(1):21224. doi: 10.7448/IAS.19.1.21224. eCollection 2016.

28.

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.

Prendergast AJ, Szubert AJ, Berejena C, Pimundu G, Pala P, Shonhai A, Musiime V, Bwakura-Dangarembizi M, Poulsom H, Hunter P, Musoke P, Kihembo M, Munderi P, Gibb DM, Spyer M, Walker AS, Klein N; ARROW Trial Team.

J Infect Dis. 2016 Jul 15;214(2):226-36. doi: 10.1093/infdis/jiw148. Epub 2016 May 18.

29.

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Crook AM, Turkova A, Musiime V, Bwakura-Dangarembizi M, Bakeera-Kitaka S, Nahirya-Ntege P, Thomason M, Mugyenyi P, Musoke P, Kekitiinwa A, Munderi P, Nathoo K, Prendergast AJ, Walker AS, Gibb DM; ARROW Trial Team.

BMC Med. 2016 Mar 23;14:50. doi: 10.1186/s12916-016-0593-7.

30.

Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda.

Mumpe-Mwanja D, Verver S, Yeka A, Etwom A, Waako J, Ssengooba W, Matovu JK, Wanyenze RK, Musoke P, Mayanja-Kizza H.

Afr Health Sci. 2015 Sep;15(3):851-60. doi: 10.4314/ahs.v15i3.20.

31.

Effect of subsequent pregnancies on HIV disease progression among women in the Mulago Hospital MTCT-Plus program in Uganda.

Amongin D, Nakimuli A, Busingye R, Mubiru M, Musoke P, Mutyaba T.

Int J Gynaecol Obstet. 2016 Mar;132(3):347-52. doi: 10.1016/j.ijgo.2015.09.015. Epub 2015 Dec 31.

32.

Motivations and concerns about adolescent tuberculosis vaccine trial participation in rural Uganda: a qualitative study.

Buregyeya E, Kulane A, Kiguli J, Musoke P, Mayanja H, Mitchell EM.

Pan Afr Med J. 2015 Sep 30;22:76. doi: 10.11604/pamj.2015.22.76.7097. eCollection 2015.

33.

Use of peers, community lay persons and Village Health Team (VHT) members improves six-week postnatal clinic (PNC) follow-up and Early Infant HIV Diagnosis (EID) in urban and rural health units in Uganda: A one-year implementation study.

Namukwaya Z, Barlow-Mosha L, Mudiope P, Kekitiinwa A, Matovu JN, Musingye E, Ssebaggala JN, Nakyanzi T, Abwooli JJ, Mirembe D, Etima J, Bitarakwate E, Fowler MG, Musoke PM; Peer-senga study Group at Mulago, Mengo, Rubaga and Mpigi Health Units.

BMC Health Serv Res. 2015 Dec 15;15:555. doi: 10.1186/s12913-015-1213-5.

34.

Successful Global Health Research Partnerships: What Makes Them Work?

John CC, Ayodo G, Musoke P.

Am J Trop Med Hyg. 2016 Jan;94(1):5-7. doi: 10.4269/ajtmh.15-0611. Epub 2015 Oct 19.

35.

A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study".

Kiweewa FM, Bakaki PM, McConnell MS, Musisi M, Namirembe C, Nakayiwa F, Kusasira F, Nakintu D, Mubiru MC, Musoke P, Fowler MG.

BMC Public Health. 2015 Sep 29;15:988. doi: 10.1186/s12889-015-2345-6.

36.

Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study.

Wobudeya E, Lukoye D, Lubega IR, Mugabe F, Sekadde M, Musoke P.

BMC Public Health. 2015 Sep 25;15:967. doi: 10.1186/s12889-015-2312-2.

37.

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.

Musoke P, Szubert AJ, Musiime V, Nathoo K, Nahirya-Ntege P, Mutasa K, Williams DE, Prendergast AJ, Spyer M, Walker AS, Gibb DM; ARROW Trial Team.

AIDS. 2015 Aug 24;29(13):1623-1632. doi: 10.1097/QAD.0000000000000749.

38.

Pertussis prevalence and its determinants among children with persistent cough in urban Uganda.

Kayina V, Kyobe S, Katabazi FA, Kigozi E, Okee M, Odongkara B, Babikako HM, Whalen CC, Joloba ML, Musoke PM, Mupere E.

PLoS One. 2015 Apr 15;10(4):e0123240. doi: 10.1371/journal.pone.0123240. eCollection 2015.

39.

Prevalence and immediate outcome of candida colonized preterm neonates admitted to Special Care Unit of Mulago Hospital, Kampala Uganda.

Abdallah Y, Kaddu-Mulindwa D, Nankunda J, Musoke PM.

Afr Health Sci. 2015 Mar;15(1):197-205. doi: 10.4314/ahs.v15i1.26.

40.

Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.

Ssengooba W, Gelderbloem SJ, Mboowa G, Wajja A, Namaganda C, Musoke P, Mayanja-Kizza H, Joloba ML.

Health Res Policy Syst. 2015 Jan 15;13:4. doi: 10.1186/1478-4505-13-4.

41.

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

Naranbhai V, Moodley D, Chipato T, Stranix-Chibanda L, Nakabaiito C, Kamateeka M, Musoke P, Manji K, George K, Emel LM, Richardson P, Andrew P, Fowler M, Fletcher H, McShane H, Coovadia HM, Hill AV; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):573-5. doi: 10.1097/QAI.0000000000000353.

42.

Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study.

Massavon W, Barlow-Mosha L, Mugenyi L, McFarland W, Gray G, Lundin R, Costenaro P, Nannyonga MM, Penazzato M, Bagenda D, Namisi CP, Wabwire D, Mubiru M, Kironde S, Bilardi D, Mazza A, Fowler MG, Musoke P, Giaquinto C.

ISRN AIDS. 2014 Apr 1;2014:852489. doi: 10.1155/2014/852489. eCollection 2014.

43.

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.

Fillekes Q, Kendall L, Kitaka S, Mugyenyi P, Musoke P, Ndigendawani M, Bwakura-Dangarembizi M, Gibb DM, Burger D, Walker AS; ARROW Trial Team.

Pediatr Infect Dis J. 2014 May;33(5):495-8. doi: 10.1097/INF.0000000000000143.

44.

Two year mortality and associated factors in a cohort of children from rural Uganda.

Nabongo P, Verver S, Nangobi E, Mutunzi R, Wajja A, Mayanja-Kizza H, Kadobera D, Galiwango E, Colebunders R, Musoke P.

BMC Public Health. 2014 Apr 5;14:314. doi: 10.1186/1471-2458-14-314.

45.

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74. doi: 10.1097/QAI.0000000000000052.

46.

Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants.

Lutwama F, Kagina BM, Wajja A, Waiswa F, Mansoor N, Kirimunda S, Hughes EJ, Kiwanuka N, Joloba ML, Musoke P, Scriba TJ, Mayanja-Kizza H, Day CL, Hanekom WA.

J Infect Dis. 2014 Mar;209(6):887-97. doi: 10.1093/infdis/jit570. Epub 2013 Oct 31.

47.

Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.

Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Allen M, Jackson JB, Fowler MG, Guay LA.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):464-71. doi: 10.1097/QAI.0000000000000015.

48.

Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.

Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):268-77. doi: 10.1097/01.qai.0000435600.65845.31.

49.

Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda.

Waako J, Verver S, Wajja A, Ssengooba W, Joloba ML, Colebunders R, Musoke P, Mayanja-Kizza H.

BMC Infect Dis. 2013 Jul 26;13:349. doi: 10.1186/1471-2334-13-349.

50.

Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial.

Kiweewa FM, Wabwire D, Nakibuuka J, Mubiru M, Bagenda D, Musoke P, Fowler MG, Antelman G.

J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):e125-32. doi: 10.1097/QAI.0b013e3182987ce6.

PMID:
23807157

Supplemental Content

Loading ...
Support Center